RLX (hydrochloride), CAS [[21314-60-3]] Preis auf Anfrage

Catalog Number: MCE-HY-116604A
Article Name: RLX (hydrochloride), CAS [[21314-60-3]] Preis auf Anfrage
Biozol Catalog Number: MCE-HY-116604A
Supplier Catalog Number: HY-116604A
Alternative Catalog Number: MCE-HY-116604A-1UNIT
Manufacturer: MedchemExpress
Category: Biochemikalien
Alternative Names: PD 139530 (hydrochloride)
RLX (PD 139530) hydrochloride is the hydrochloride of RLX (HY-116604). RLX is a PI3K/Akt/FoxO3a signaling inhibitor, possessing significant therapeutic potential in experimental colon cancer. RLX can effectively modulate the tumor microenvironment, enhancing the efficacy of cancer immunotherapy. RLX demonstrates the ability to improve the retention time of therapeutic agents within the tumor microenvironment by utilizing advanced nanoparticle delivery systems. RLX can be integrated with various treatment modalities, such as chemotherapy and radiotherapy, to enhance overall tumor therapy effectiveness[1].
Molecular Weight: 250.72
CAS Number: [21314-60-3]
Formula: C13H15ClN2O
Target: Akt,PI3K
Application Notes: MCE Product type: Reference compound